CFH and atypical hemolytic-uremic syndrome: Mutations in the factor H sialyl-recognition domain can cause atypical hemolytic uremic syndrome (aHUS), a disorder characterized by increased C3b deposition and lysis of blood cells (Hyvarinen et al., 2016) indicating that the factor H-sialic acid interaction is a key regulator of the alternative pathway of complement activation.